Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes

Clinical trial NCT04567628 · COMPLETED

Trial details

NCT number: NCT04567628
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Inflammatory Bowel Diseases Colitis, Ulcerative Crohn Disease

Start date: 2020-10-05
Primary completion: 2021-09-22
Enrollment: 7873

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.